Posted Aug. 26, 2010 at 1:45 p.m.

Premium Lock Chapel Hill startup, armed with $15M in funding, advances drug candidate

Published: 2010-08-26 13:45:04
Updated: 2010-08-26 13:45:04

Cardioxyl Cardioxyl

Cardioxyl Pharmaceuticals, which is backed by Aurora Funds, is developing treatment for heart failure....

Read More
Read More

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders